Gitelman's syndrome presenting as intolerance to statin therapy

Annals of Clinical Biochemistry

Volumn 42, Issue 3, 2005, Pages 232-233

  Freedman, Danielle B ^a   Housley, David ^a  

^a LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ATORVASTATIN; GLYCEROPHOSPHATE; GLYCEROPHOSPHATE MAGNESIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM DERIVATIVE; POTASSIUM CHLORIDE; PRAVASTATIN; SIMVASTATIN; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; DEPRESSION; DISEASE PREDISPOSITION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GASTROINTESTINAL DISEASE; GITELMAN SYNDROME; HEADACHE; HUMAN; HYPOCALCIURIA; HYPOKALEMIA; HYPOMAGNESEMIA; KALIURESIS; MYALGIA; MYOPATHY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AMILORIDE; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPOKALEMIA; KIDNEY DISEASES; MAGNESIUM; MUSCULAR DISEASES; PAIN; POTASSIUM; PRAVASTATIN; SPIRONOLACTONE; SYNDROME;

EID: 18844389522     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053857770     Document Type: Article

References (9)

1. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003; 289: 1681-90
2. CSM/MCA Current problems in pharmacovigilance. 2002, 28, 8-9. Available at: http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/currentproblems/ cpprevious.htm#2002
3. Sayer JA, Pearce SHS. Diagnosis and clinical biochemistry of inherited tubulopathies. Ann Clin Biochem 2001; 38: 459-70
4. Durrington P. Dyslipidaemia. Lancet 2003; 362: 717-31
5. Smilde TJ, Van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357: 577-81
6. Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109(Suppl III): III50-7
7. Jamal SM, Eisenberg MJ, Christopoulos S. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J 2003; 147: 956-65
8. Rosenson RS. Current overview of statin-induced myopathy. Am J Med 2004; 116: 408-16
9. Sinzinger H, O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol 2004; 57: 525-8